应激性高血糖比值与急性轻型缺血性卒中或高危短暂性脑缺血发作的不良结局:INSPIRES试验的二次分析
该研究为INSPIRES随机临床试验的二次分析,纳入4515例由颅内或颅外动脉粥样硬化所致的急性轻型缺血性卒中或高危短暂性脑缺血发作患者,评估应激性高血糖比值(SHR)与90天不良结局的关联。多变量Cox回归显示,校正混杂因素后,SHR最高四分位组(Q4)较低四分位组(Q1)复发卒中、复合血管事件、复发性缺血性卒中、功能结局不良及早期神经功能恶化的风险均显著增加,而SHR与安全性结局无显著关联。
要点
- SHR升高与轻型缺血性卒中或高危TIA患者90天复发卒中风险独立相关。
- SHR最高四分位组功能结局不良和早期神经功能恶化风险亦显著增加。
- SHR与中重度出血等安全性结局无显著关联。
核心结论
- 在 presumed 动脉粥样硬化性急性轻型缺血性卒中或高危TIA患者中,升高的SHR水平与复发卒中、复合血管事件、复发性缺血性卒中、功能结局不良及早期神经功能恶化的风险增加独立相关。
研究设计与样本
- INSPIRES随机临床试验的二次分析,最终纳入6100例患者中的4515例进行分析。
- SHR计算公式为入院血糖(mmol/L)除以(1.59×HbA1c[%]-2.59)。
- 采用多变量Cox回归模型评估SHR与不良临床结局的关联,校正年龄、性别及其他潜在因素。
主要发现
- 90天随访期间,复发卒中发生356例(7.88%),复合血管事件363例(8.04%),复发性缺血性卒中340例(7.53%),功能结局不良474例(10.51%),早期神经功能恶化196例(4.34%)。
- 与SHR最低四分位组(Q1)相比,最高四分位组(Q4)复发卒中风险显著增加(HR 1.84,95%CI 1.30-2.61)。
- Q4组复合血管事件风险显著增加(HR 1.72,95%CI 1.22-2.41),复发性缺血性卒中风险显著增加(HR 1.79,95%CI 1.25-2.55)。
- Q4组功能结局不良风险显著增加(HR 1.56,95%CI 1.13-2.15),早期神经功能恶化风险显著增加(HR 1.62,95%CI 1.00-2.61)。
- SHR与任何安全性结局均无显著关联。
临床怎么用
- 对于急性轻型缺血性卒中或高危TIA且推测动脉粥样硬化性病因的患者,可计算SHR以辅助识别90天不良结局高风险个体。
局限性
- 本研究为INSPIRES试验的二次分析,结果需在更广泛人群中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence on the association between the stress hyperglycemia ratio (SHR) and adverse outcomes in patients with mild ischemic stroke (IS) or high-risk transient ischemic attack remains limited. METHODS: This was a secondary analysis of the INSPIRES (Intensive Statin and Antiplatelet Therapy for Acute High-Risk Intracranial or Extracranial Atherosclerosis) randomized clinical trial. SHR was calculated as admission blood glucose (mmol/L) divided by (1.59* HbA1c [%]-2.59). Multivariable Cox regression models were used to assess the association between SHR and adverse clinical outcomes, adjusting for age, sex, and other potential factors. The primary efficacy outcome was any stroke (ischemic or hemorrhagic) within 90 days. Secondary efficacy outcomes comprised composite vascular events, recurrent IS, poor functional outcome, and early neurological deterioration. The primary safety outcome was moderate-to-severe bleeding within 90 days. RESULTS: The INSPIRES trial, ultimately enrolled 6100 patients with mild IS or high-risk transient ischemic attack caused by intracranial or extracranial atherosclerosis, of whom 4515 were included in this secondary analysis. The median age was 65 years (interquartile range, 57-71), and 2894 (64.10%) were male. During the 90-day follow-up, recurrent stroke occurred in 356 patients (7.88%), composite vascular events in 363 (8.04%), recurrent IS in 340 (7.53%), poor functional outcome in 474 (10.51%), and early neurological deterioration in 196 (4.34%). After adjustment for conventional confounders, compared with patients in the lower SHR group (Q1), those with higher SHR levels (Q4) had significantly increased risks of recurrent stroke (hazard ratio [HR], 1.84 [95% CI, 1.30-2.61]), composite vascular events (HR, 1.72 [95% CI, 1.22-2.41]), recurrent IS (HR, 1.79 [95% CI, 1.25-2.55]), poor functional outcome (HR, 1.56 [95% CI, 1.13-2.15]), and early neurological deterioration (HR, 1.62 [95% CI, 1.00-2.61]). In contrast, SHR was not significantly associated with any safety outcomes. CONCLUSIONS: Among patients with acute mild IS or high-risk transient ischemic attack of presumed atherosclerotic cause, elevated SHR levels were independently associated with increased risks of recurrent stroke, composite vascular events, recurrent IS, poor functional outcome, and early neurological deterioration.
引用
- Li W, Yan H, Gao Y, et al. Stress Hyperglycemia Ratio and Adverse Outcomes in Acute Mild Ischemic Stroke or High-Risk Transient Ischemic Attack: A Secondary Analysis of the INSPIRES Trial. Stroke. 2025. PMID: 41332377. doi:10.1161/STROKEAHA.125.052987
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。